Business

RETRANSMISSION: NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025

This release is being retransmitted for extra exposure to downstream sites. SHELTON, CT / ACCESS Newswire / September 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...

articleNanoviricides, Inc.September 11, 202511/company/nanoviricides-inc/news/retransmission-nanoviricides-to-present-at-the-life-science-executive-partnering-lsx-congress-in-boston-on-september-17-2025
RETRANSMISSION: NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025

About this update from Nanoviricides, Inc.

[{"type":"text","content":"This release is being retransmitted for extra exposure to downstream sites.","length":75,"tagName":"p"},{"type":"text","content":"SHELTON, CT / ACCESS Newswire / September 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be presenting on Wednesday, September 17th, at 12:30pm at the Life Science Executive Partnering ("LSX") World Congress 2025 in Boston, MA.","length":402,"tagName":"p"},{"type":"text","content":"Event Information:","length":18,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"border:1.0pt solid black;height:12.9pt;padding:2.0pt 2.0pt 2.0pt 16.4pt;width:78.55pt;","val":[{"type":"text","content":"Event","length":5,"tagName":"p","attribs":{}}]},{"style":"border-bottom-style:solid;border-color:black;border-left-style:none;border-right-style:solid;border-top-style:solid;border-width:1.0pt;height:12.9pt;padding:2.0pt 2.0pt 2.0pt 16.4pt;width:388.4pt;","val":[{"type":"text","content":"NanoViricides Presentation at the LSX World Congress, 2025, Boston, MA","length":70,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"border-bottom-style:solid;border-color:black;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:12.75pt;padding:2.0pt 2.0pt 2.0pt 16.4pt;width:78.55pt;","val":[{"type":"text","content":"Day & Date","length":14,"tagName":"p","attribs":{}}]},{"style":"border-bottom:1.0pt solid black;border-left-style:none;border-right:1.0pt solid black;border-top-style:none;height:12.75pt;padding:2.0pt 2.0pt 2.0pt 16.4pt;width:388.4pt;","val":[{"type":"text","content":"Wednesday, September 17, 2025","length":29,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"border-bottom-style:solid;border-color:black;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:12.75pt;padding:2.0pt 2.0pt 2.0pt 16.4pt;width:78.55pt;","val":[{"type":"text","content":"Time","length":4,"tagName":"p","attribs":{}}]},{"style":"border-bottom:1.0pt solid black;border-left-style:none;border-right:1.0pt solid black;border-top-style:none;height:12.75pt;padding:2.0pt 2.0pt 2.0pt 16.4pt;width:388.4pt;","val":[{"type":"text","content":"12:30 pm","length":8,"tagName":"p","att...

More updates from Nanoviricides, Inc.

NanoViricidesdrug candidateThe Companyantiviral drugsdrug candidatesLSX World Congresshuman virusesWorld CongressThomas Michael MeninoNanoViricides, Inc.pathogenic virusesCompany